Reference
Terrero G, et al. Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants. JAMA Oncology 8: 938-940, No. 6, Jun 2022. Available from: URL: http://doi.org/10.1001/jamaoncol.2022.0611
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1934, 49 (2022). https://doi.org/10.1007/s40278-022-28430-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-28430-0